Kohorn EI - Search Results

1

Chambers JT, Merino MJ, Kohorn EI, Schwartz PE. Chambers JT, et al. Among authors: kohorn ei. Am J Obstet Gynecol. 1988 Nov;159(5):1088-94. doi: 10.1016/0002-9378(88)90419-x. Am J Obstet Gynecol. 1988. PMID: 3189441

2

Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial.

Schwartz PE, Chambers JT, Kohorn EI, Chambers SK, Weitzman H, Voynick IM, MacLusky N, Naftolin F. Schwartz PE, et al. Among authors: kohorn ei. Cancer. 1989 Mar 15;63(6):1074-8. doi: 10.1002/1097-0142(19890315)63:6<1074::aid-cncr2820630606>3.0.co;2-0. Cancer. 1989. PMID: 2917311 Clinical Trial.

3

Evaluation of the role of second-look surgery in ovarian cancer.

Chambers SK, Chambers JT, Kohorn EI, Lawrence R, Schwartz PE. Chambers SK, et al. Among authors: kohorn ei. Obstet Gynecol. 1988 Sep;72(3 Pt 1):404-8. Obstet Gynecol. 1988. PMID: 3405557

4

Are cytosol estrogen and progestin receptors of prognostic significance in the management of epithelial ovarian cancers?

Schwartz PE, MacLusky N, Merino MJ, Livolsi VA, Kohorn EI, Eisenfeld A. Schwartz PE, et al. Among authors: kohorn ei. Obstet Gynecol. 1986 Dec;68(6):751-8. Obstet Gynecol. 1986. PMID: 3785785

5

Uterine papillary serous carcinoma.

Chambers JT, Merino M, Kohorn EI, Peschel RE, Schwartz PE. Chambers JT, et al. Among authors: kohorn ei. Obstet Gynecol. 1987 Jan;69(1):109-13. Obstet Gynecol. 1987. PMID: 3796910

6

A phase II study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed müllerian tumors (MMT) of the uterus.

Resnik E, Chambers SK, Carcangiu ML, Kohorn EI, Schwartz PE, Chambers JT. Resnik E, et al. Among authors: kohorn ei. Gynecol Oncol. 1995 Mar;56(3):370-5. doi: 10.1006/gyno.1995.1065. Gynecol Oncol. 1995. PMID: 7705670 Free article. Clinical Trial.

7

Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival.

Price FV, Chambers SK, Chambers JT, Carcangiu ML, Schwartz PE, Kohorn EI, Stanley ER, Kacinski BM. Price FV, et al. Among authors: kohorn ei. Am J Obstet Gynecol. 1993 Feb;168(2):520-7. doi: 10.1016/0002-9378(93)90485-2. Am J Obstet Gynecol. 1993. PMID: 8438921

8

Combination chemotherapy with etoposide, cisplatin, and doxorubicin in mixed müllerian tumors of the adnexa.

Cass I, Resnik E, Chambers JT, Chambers SK, Carcangiu ML, Kohorn EI, Schwartz PE. Cass I, et al. Among authors: kohorn ei. Gynecol Oncol. 1996 Jun;61(3):309-14. doi: 10.1006/gyno.1996.0148. Gynecol Oncol. 1996. PMID: 8641607 Free article.

9

Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide.

Chambers JT, Chambers SK, Kohorn EI, Carcangiu ML, Schwartz PE. Chambers JT, et al. Among authors: kohorn ei. Gynecol Oncol. 1996 Mar;60(3):438-42. doi: 10.1006/gyno.1996.0070. Gynecol Oncol. 1996. PMID: 8774654 Free article.

10

Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study.

Chambers SK, Davis CA, Schwartz PE, Kohorn EI, Chambers JT. Chambers SK, et al. Among authors: kohorn ei. Clin Cancer Res. 1996 Oct;2(10):1693-7. Clin Cancer Res. 1996. PMID: 9816118 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters